About India Glycols Ltd
India Glycols is engaged in manufactures Bio-based Specialities and Performance Chemicals such as green technology based bulk, natural gums and industrial gases; Potable Spirits, Boi-Fuel and Ennature Biopharma.
Founded
1983
CEO
U S Bhartia
Employees
3,951
HQ
Kolkata, India
Finished Products
1Ethyl Alcohol (Potable)
₹12,312.31Cr2Ethyl Alcohol
₹11,011.15Cr3Glycol-Heavy
₹4,727.92Cr4Power Alcohol (DAE)
₹2,639.50Cr5Nutraceuticals
₹813.63Cr6Chemicals & Oil Products
₹568.27Cr7Others
₹512.25Cr1–7 of 15
Raw Materials
1Raw Material Consumed
₹6,718.12Cr2Chemicals & Oil Products
₹779.42CrAbout India Glycols Ltd
India Glycols is engaged in manufactures Bio-based Specialities and Performance Chemicals such as green technology based bulk, natural gums and industrial gases; Potable Spirits, Boi-Fuel and Ennature Biopharma.
Founded:1983
CEO:U S Bhartia
Employees:3,951
HQ:Kolkata, India
Finished Products
1Ethyl Alcohol (Potable)
₹12,312.31Cr2Ethyl Alcohol
₹11,011.15Cr3Glycol-Heavy
₹4,727.92Cr4Power Alcohol (DAE)
₹2,639.50Cr5Nutraceuticals
₹813.63Cr6Chemicals & Oil Products
₹568.27Cr7Others
₹512.25Cr1–7 of 15
Raw Materials
1Raw Material Consumed
₹6,718.12Cr2Chemicals & Oil Products
₹779.42CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹247
52W Low
₹160
Volume115.19K
Avg VolumeN/A
Beta1.16
Dividend Yield3.11%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
5.11x
Valuation
P/B Ratio
0.55x
Valuation
EPS
₹47.20
Valuation
Dividend Yield
3.11%
Valuation
ROE
9.98%
Profitability
ROCE
11.61%
Profitability
Revenue by Segment
Contribution & growth by business line
Potable Spirits
+8.0%70.7%
₹6,946.43 Cr
Bio-Fuel
+40.9%15.0%
₹1,469.93 Cr
Bio-based Specialities and Performa
-10.4%12.2%
₹1,202.5 Cr
Ennature Biopharma
-5.3%2.1%
₹207.77 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
94.9%
International
5.1%
Domestic94.9%
Other Countries2.3%
Indonesia1.3%
South Korea0.8%
Taiwan0.3%
Japan0.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
S
Scientific Design Inc
United States
0.00% stakeB
Biotim NV
Belgium
0.00% stakeS
Sanyo Chemical Industries Ltd
Japan
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.58x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
8.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.